 |
(S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one |
|---|---|
| Trade Name | |
| Orphan Indication | Chronic lymphocytic leukemia and small lymphocytic lymphoma |
| USA Market Approval | USA |
| USA Designation Date | 2013-04-15 00:00:00 |
| Sponsor | Infinity Pharmaceuticals;780 Memorial Drive;Cambridge, MA, 02139 |
